Abstract
We designed a series of pyrazole-based carboxylic acids as candidate ligands of heart fatty acid binding protein (H-FABP, or FABP3), based on a comparison of the X-ray crystallographic structures of adipocyte fatty acid binding protein (FABP4)-selective inhibitor (BMS309403) complex and FABP3-elaidic acid complex. Some of the synthesized compounds exhibited dual FABP3/4 ligand activity, and some exhibited selectivity for FABP3.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Binding Sites
-
Biphenyl Compounds / chemistry
-
Crystallography, X-Ray
-
Drug Design*
-
Fatty Acid Binding Protein 3
-
Fatty Acid-Binding Proteins / chemistry*
-
Fatty Acid-Binding Proteins / metabolism
-
Humans
-
Kinetics
-
Ligands
-
Molecular Docking Simulation
-
Protein Binding
-
Protein Structure, Tertiary
-
Pyrazoles / chemical synthesis
-
Pyrazoles / chemistry*
-
Pyrazoles / metabolism
Substances
-
2-(2'-(5-ethyl-3,4-diphenyl-1H-pyrazol-1-yl)biphenyl-3-yloxy)acetic acid
-
Biphenyl Compounds
-
FABP3 protein, human
-
FABP4 protein, human
-
Fatty Acid Binding Protein 3
-
Fatty Acid-Binding Proteins
-
Ligands
-
Pyrazoles
-
pyrazole